Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival

Transplantation

Volumn 66, Issue 4, 1998, Pages 426-434

  Judge, Thomas A ^a,b   Desai, N M ^a   Yang, Z ^a   Rostami, S ^a   Alonso, L ^a   Zhang, H ^a   Chen, Y ^a   Markman, J F ^a   DeMateo, R P ^a   Barker, C F ^a   Naji, A ^a   Turka, Laurence A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; INSULIN;

ADENOVIRUS; ALLOGRAFT; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; GRAFT SURVIVAL; HUMAN; HUMAN CELL; INSULIN RELEASE; LIVER INJURY; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; MOUSE; MYOBLAST; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; FAS LIGAND PROTEIN; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; TRANSFECTION;

EID: 0032572797     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00003     Document Type: Article

References (38)

1. Abbas AK. Die and let live: eliminating dangerous lymphocytes. Cell 1996; 84: 655.
2. Darmon AJ, Bleackley RC. An interleukin-1β converting enzyme-like protease is a key component of Fas-mediated apoptosis. J Biol Chem 1996; 271: 21699.
3. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32- like proteases during Fas-mediated apoptosis. Nature 1996; 380: 723.
4. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39.
5. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez C, Abbas AK. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol 1994; 6: 913.
6. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lympho- proliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314.
7. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
8. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7.
9. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
10. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
11. Korbutt GS, Smith DK, Rajotte RV, Elliott JF. Expression of β-galactosidase in mouse pancreatic islets by adenoviral-mediated gene transfer. Transplant Proc 1995; 27: 3414.
12. DeMatteo RP, Raper SE, Ahn M, et al. Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. Ann Surg 1995; 222: 229.
13. Csete ME, Afra R, Mullen Y, Drazan KE, Benhamou PY, Shaked A. Adenoviral-mediated gene transfer to pancreatic islets does not alter islet function. Transplant Proc 1994; 26: 756.
14. Csete ME, Benhamou PY, Drazan KE, et al. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 1995; 59: 263.
15. Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF. Interleukin-4 and interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent β cell destruction in diabetic NOD mice. Transplantation 1997; 64: 1040.
16. Zhang H, Yang Y, Horton JL, et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest 1997; 100: 1951.
17. Herz J, Gerald RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812.
18. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145: 185.
19. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994; 10: 41.
20. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181.
21. Lacy PE, Walker MM, Fink CJ. Perifusion of isolated rat islets in vitro. Diabetes 1972; 21: 987.
22. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity. Transplantation 1995; 60: 221.
23. Muruve DA, Nicolson AG, Manfro RC, Strom TB, Sukhatme VP, Libermann TA. Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apotosis of ex vivo-infected pancreatic islet allografts and isografts. Hum Gene Ther 1997; 8: 955.
24. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806.
25. Allison J, Georgiou HM, Strasser A, Vaux DL. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privelege upon islet allografts. Proc Natl Acad Sci USA 1997; 94: 3943.
26. Kang S-M, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997; 3: 738.
27. Qin L, Chavin KD, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316.
28. Qin L, Chavin KD, Ding Y, et al. Gene transfer for transplantation: prolongation of allograft survival with transforming growth factor-β1. Ann Surg 1994; 220: 508.
29. Chen SJ, Wilson JM, Muller DW. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994; 89: 1922.
30. Ferguson TA, Fletcher S, Herndon JM, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 1995; 155: 1746.
31. Ferguson TA, Herndon JM, Dube P. The immune response and the eye. IV. The role for tumor necrosis factor in anterior chamber associated immune deviation. Invest Opthalmol Vis Sci 1994; 35: 2643.
32. Taylor A, Streilein JW, Cousins SW. Immunoreactive VIP contributes to immunosuppressive activity of normal aqueous humor. J Immunol 1994; 153: 1080.
33. Wilbanks G, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber- associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur J Immunol 1992; 22: 1031.
34. Selawry HP, Cameron DF. Sertoli-cell enriched fractions in successful islet cell transplantation. Cell Transplant 1993; 2: 123.
35. Korbutt GS, Elliot JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46: 317.
36. Nunes FA, Raper SE. Liver-directed gene therapy. Med Clin North Am 1996; 80: 1201.
37. Giordano C, Stassi R, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 257: 960.
38. Tripathy S, Black H, Goldwasser E, Leiden J. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996; 2: 545.